AUROSOURCE
- Aurobindo Pharma eyes 25% revenue from custom research businessAurobindo Pharma is eyeing to garner at least 25% of its annual revenues from the custom research and manufacturing (Crams) business in the...
- Load More
Domestic PCB manufacturing to save Rs 40,000 crore imports annually: Ashwini Vaishnaw
Sagar Adani urges faster electrification, energy storage
Touchline men: From miracle makers to master tacticians, the World Cup belongs to the manager
Sarovar Hotels plans to double branded residences portfolio
Maharashtra TET postponed after question paper leak
Iran coach: US treatment at World Cup 'really terrible'
At the big Wimbledon, top seeds seek to erase imperfections from near perfect year
Copyright © 2026 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights:
Times Syndication Service